DE59306234D1 - Verfahren zur Herstellung von 5-Chloroxindol - Google Patents

Verfahren zur Herstellung von 5-Chloroxindol

Info

Publication number
DE59306234D1
DE59306234D1 DE59306234T DE59306234T DE59306234D1 DE 59306234 D1 DE59306234 D1 DE 59306234D1 DE 59306234 T DE59306234 T DE 59306234T DE 59306234 T DE59306234 T DE 59306234T DE 59306234 D1 DE59306234 D1 DE 59306234D1
Authority
DE
Germany
Prior art keywords
image
general formula
preparation
formula
chloronitrobenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59306234T
Other languages
German (de)
English (en)
Inventor
Rene Dr Imwinkelried
Felix Dr Previdoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Application granted granted Critical
Publication of DE59306234D1 publication Critical patent/DE59306234D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
DE59306234T 1992-05-13 1993-05-11 Verfahren zur Herstellung von 5-Chloroxindol Expired - Fee Related DE59306234D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH152892 1992-05-13

Publications (1)

Publication Number Publication Date
DE59306234D1 true DE59306234D1 (de) 1997-05-28

Family

ID=4212552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59306234T Expired - Fee Related DE59306234D1 (de) 1992-05-13 1993-05-11 Verfahren zur Herstellung von 5-Chloroxindol

Country Status (20)

Country Link
US (2) US5284960A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0570817B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0632777A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930023341A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (2) CN1033581C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE152101T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU658060B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9301786A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2096043A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (2) CZ283241B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE59306234D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0570817T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2103044T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI932146A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3023357T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU213634B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (3) IL105657A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO179324C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL173037B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK278473B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526173T2 (de) * 1994-11-04 2002-09-26 K I Chemical Industry Co., Ltd. Verfahren zur Herstellung von Oxyindolen
US6469181B1 (en) 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060626A (en) * 1972-01-26 1977-11-29 Boehringer Mannheim G.M.B.H. Indole-carboxylic carbon compounds and pharmaceutical compositions containing them
US4160032A (en) * 1973-11-21 1979-07-03 Sandoz, Inc. Oxindoles as sleep-inducers
US3882236A (en) * 1973-12-26 1975-05-06 Lilly Co Eli Pharmaceutical compositions containing substituted 2-oxo-indolines and the use thereof to treat anxiety and tension
US4476315A (en) * 1982-04-30 1984-10-09 Ethyl Corporation Nucleophilic substitution process
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4659862A (en) * 1984-05-03 1987-04-21 E. I. Du Pont De Nemours And Company Process of preparing nitrodihydroaryl carbonyl compounds
US4730004A (en) * 1986-01-22 1988-03-08 Pfizer Inc. Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides
US4761485A (en) * 1987-03-11 1988-08-02 Pfizer Inc. Synthetic method for indol-2(3H)-ones

Also Published As

Publication number Publication date
ES2103044T3 (es) 1997-08-16
ATE152101T1 (de) 1997-05-15
FI932146L (fi) 1993-11-14
NO931732L (no) 1993-11-15
CN1079959A (zh) 1993-12-29
IL119258A0 (en) 1996-12-05
SK47393A3 (en) 1994-04-06
SK278473B6 (en) 1997-07-09
CN1033581C (zh) 1996-12-18
CN1144795A (zh) 1997-03-12
IL105657A0 (en) 1993-09-22
HU9301396D0 (en) 1993-09-28
PL298918A1 (en) 1993-11-29
NO931732D0 (no) 1993-05-12
NO179324C (no) 1996-09-18
US5395963A (en) 1995-03-07
CZ87593A3 (en) 1994-01-19
HU213634B (en) 1997-08-28
IL105657A (en) 1997-04-15
US5284960A (en) 1994-02-08
GR3023357T3 (en) 1997-08-29
DK0570817T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-05-20
FI932146A0 (fi) 1993-05-12
BR9301786A (pt) 1993-11-16
CZ219297A3 (cs) 1998-02-18
EP0570817B1 (de) 1997-04-23
CZ283021B6 (cs) 1997-12-17
JPH0632777A (ja) 1994-02-08
FI932146A7 (fi) 1993-11-14
KR930023341A (ko) 1993-12-18
HUT64743A (en) 1994-02-28
PL173037B1 (pl) 1998-01-30
EP0570817A1 (de) 1993-11-24
CA2096043A1 (en) 1993-11-14
NO179324B (no) 1996-06-10
IL119258A (en) 1998-09-24
AU3839993A (en) 1993-12-16
CZ283241B6 (cs) 1998-02-18
AU658060B2 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
DE69207429D1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE106078T1 (de) Verfahren zur herstellung von mono-, bi- und tricyclischen aminosäuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung.
ATE101124T1 (de) Verfahren zur herstellung von aminocyanacetamid.
DE69105338D1 (de) Verfahren zur Herstellung von 1-(2,3,4-Trimethoxybenzyl)-Piperazin durch reduktive Aminierung.
DE59306234D1 (de) Verfahren zur Herstellung von 5-Chloroxindol
DE69426979D1 (de) Verfahren zur herstellung von hiv-proteasehemmern
ATE119533T1 (de) Verfahren zur herstellung von 1-oxa-3, 8-diaza-4- oxo-spiro-(4,5>decan-verbindungen.
ATE176463T1 (de) Verfahren zur herstellung von 2-substituierten 4,6-dialkoxypyrimidinen
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
DE59309077D1 (de) Verfahren zur Herstellung von 2-Halogen-4,6-dialkoxypyrimidinen
DE69404932D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
ATE554T1 (de) Verfahren zur herstellung von 4-amino-diphenylaminen.
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester
ATE57929T1 (de) Verfahren zur herstellung von 1h-pyrrolizin-3,5- (2h,6h)-dionen.
DE69007041D1 (de) Verfahren zur Herstellung von Synergistinen.
DE69405507D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
ATE123758T1 (de) Verfahren zur herstellung von sekundären aliphatischen unsymmetrischen alkylaminen.
ATE136028T1 (de) Verfahren zur herstellung von piperazinylpyrimidin-derivaten
ATE93845T1 (de) Verfahren zur herstellung von 4,4'-bis-(4aminophenoxy)-diphenylsulfon.
ATE1190T1 (de) Verfahren zur herstellung von n-substituierten acrylamiden.
DE69702171D1 (de) Verfahren zur Herstellung von Aminoalkynen
ATE165814T1 (de) Verfahren zur herstellung von 5-oxohexannitrilen und die verbindung 2,4-dimethyl-5-oxo- hexannitrile

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee